CLINICAL_TRIALS
trial_result
· 2023-03-14
Clinical Trial Update: A Long-Term Treatment Study of ACH-0144471 in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) [Phase 2]
Summary
Phase 2 long-term study of ACH-0144471 in paroxysmal nocturnal hemoglobinuria completed with results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Paroxysmal Nocturnal Hemoglobinuria | Phase 2 | Status: COMPLETED | Results posted: 2023-03-14